Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

3.7K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.7K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

3.6K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.6K
Bone Remodeling01:40

Bone Remodeling

40.1K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

10.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Isolation and biological characteristics of a strain of broad spectrum phage infecting <i>Enterobacter xiangfangensis</i>].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2026
Same author

[Evaluating the efficiency of 24 secondary triage strategies for detecting cervical lesions of self-collected high-risk HPV-positive women].

Zhonghua fu chan ke za zhi·2026
Same author

Stress resilience: a predictor of social independence.

Anxiety, stress, and coping·2026
Same author

Genetically regulated omics integration improves genomic prediction of complex traits in pigs.

Animal : an international journal of animal bioscience·2025
Same author

[Prospective association between physical activity and mortality in patients with chronic obstructive pulmonary disease].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences·2025
Same author

The Lung Is Not a Primary Site of Platelet Biogenesis.

Physiological research·2025
Same journal

The International Menopause Society celebrates another milestone.

Climacteric : the journal of the International Menopause Society·2026
Same journal

Impact of social determinants of health on perimenopause symptom burden: insights from the Flo app.

Climacteric : the journal of the International Menopause Society·2026
Same journal

From tissue to outcome - how perioperative vaginal estrogen transforms prolapse surgery results: a systematic review and meta-analysis of clinical evidence and outcomes.

Climacteric : the journal of the International Menopause Society·2026
Same journal

Mapping menopause education for healthcare professionals: a scoping review.

Climacteric : the journal of the International Menopause Society·2026
Same journal

Portuguese osteopaths' perceptions on the management of musculoskeletal conditions in menopausal women.

Climacteric : the journal of the International Menopause Society·2026
Same journal

Perimenopausal migraine: a narrative review.

Climacteric : the journal of the International Menopause Society·2026
See all related articles

Related Experiment Video

Updated: Dec 21, 2025

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
08:56

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

1.1K

17β-Estradiol improves osteoblastic cell function through the Sirt1/NF-κB/MMP-8 pathway.

H-L Zuo1, H Xin1, X-N Yan2

  • 1Department of Gynecology and Obstetrics, Second Hospital of Hebei Medical University, Shijiazhuang, China.

Climacteric : the Journal of the International Menopause Society
|May 16, 2020
PubMed
Summary
This summary is machine-generated.

17β-estradiol enhances osteoblastic cell function and bone formation biomarkers by activating estrogen receptor-α and Sirtuin-1 (Sirt1), while inhibiting nuclear transcription factor-κB (NF-κB) and matrix metalloproteinase-8 (MMP-8). Sirt1 knockdown reversed these beneficial effects, suggesting a therapeutic role in osteoporosis.

Keywords:
17β-estradiolPostmenopausal osteoporosisSirtuin-1matrix metalloproteinase-8nuclear transcription factor-κBosteoblasts

More Related Videos

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.7K
Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
06:47

Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells

Published on: May 4, 2018

9.7K

Related Experiment Videos

Last Updated: Dec 21, 2025

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
08:56

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

1.1K
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.7K
Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
06:47

Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells

Published on: May 4, 2018

9.7K

Area of Science:

  • Endocrinology
  • Cell Biology
  • Bone Biology

Background:

  • Postmenopausal osteoporosis is a significant health concern.
  • Estrogen deficiency negatively impacts osteoblast function.
  • Identifying pathways that mediate estrogen's protective effects on bone is crucial.

Purpose of the Study:

  • To investigate the role of 17β-estradiol in modulating osteoblastic cell function.
  • To elucidate the involvement of the Sirtuin-1/nuclear transcription factor-κB/matrix metalloproteinase-8 (Sirt1/NF-κB/MMP-8) pathway in 17β-estradiol's effects.
  • To assess the potential of 17β-estradiol as a therapeutic agent for osteoporosis.

Main Methods:

  • Primary mouse osteoblasts were cultured and treated with 17β-estradiol.
  • Expression levels of estrogen receptor-α (ERα), Sirt1, NF-κB, and MMP-8 were analyzed.
  • Sirt1 was knocked down to confirm its role in mediating 17β-estradiol's effects.
  • Osteoblast function and bone formation biomarkers were assessed.

Main Results:

  • 17β-estradiol treatment improved osteoblastic cell viability and increased bone formation markers (osteocalcin, OPG, P1NP, ALP).
  • 17β-estradiol upregulated ERα and Sirt1 expression while downregulating NF-κB and MMP-8.
  • Knockdown of Sirt1 abolished the beneficial effects of 17β-estradiol on osteoblast function and signaling pathway modulation.

Conclusions:

  • 17β-estradiol enhances osteoblastic cell function through the Sirt1/NF-κB/MMP-8 pathway.
  • This pathway is critical for mediating the bone-protective effects of 17β-estradiol.
  • 17β-estradiol replacement therapy holds promise for treating postmenopausal osteoporosis.